Operationalizing Lenacapavir for PrEP in Your Health System: From Business Planning and Reimbursement to Pharmacy Readiness
The third webinar in the “Revolutionizing HIV Prevention” SYNChronicity webinar series.
As HIV prevention evolves, long-acting injectable options like lenacapavir are emerging as promising tools to expand access and adherence. Effective implementation of new interventions calls for thoughtful planning across key areas, including operations, staffing, finance, and patient access. Join our expert faculty for a webinar designed for clinic administrators and pharmacists.
This session will walk through the essential considerations for integrating lenacapavir into practice, including:
- Business Planning: Building leadership buy-in, adapting existing long-acting PrEP delivery models, assessing staffing needs, and programming EHR/EMR systems.
- Reimbursement Strategies: Evaluating buy-and-bill feasibility, 340B program considerations, insurance coverage, billing processes, and patient access/privacy safeguards.
- Site of Care & Administration: Navigating lead-in doses, injection procedures, and day-to-day operational logistics.
The webinar will feature expert-led presentations and a live Q&A to support understanding and real-world use. Participants will leave with actionable insights into how to prepare their organizations for lenacapavir implementation and ensure sustainability in delivery.
Faculty
- E. Michael Murphy, PharmD, MBA, The Ohio State University College of Pharmacy
- Daniela E. DiMarco, MD, MPH, University of Rochester Medicine Infectious Disease Clinic
- Erick Suarez, APRN, FNP-BC, AAHIV-S, Pineapple Healthcare
Other Related Trainings
Lenacapavir in Clinical Practice – A Primer for Clinicians
In the first webinar of the series, faculty – including principal investigators from the PURPOSE trials – review clinical data and delve into opportunities and challenges for the real-world implementation of lenacapavir as PrEP.
This webinar covers medication administration, managing side effects, potential drug interactions, and transitioning patients on or off lenacapavir as PrEP.
Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide
This comprehensive electronic/downloadable monograph has been developed to specifically support the needs of pharmacists now challenged to come up to speed on guidelines and protocols for HIV preexposure and postexposure prophylaxis (PrEP and PEP). Module 2 of Pharmacy PrEP Education: A “How To” Series Spanning Policy to Practice.
